Lecanemab in Early Alzheimer's Disease
N Engl J Med
.
2023 Apr 27;388(17):1630.
doi: 10.1056/NEJMc2301380.
Authors
Michael J Valenzuela
1
,
Alvaro Pascual-Leone
2
Affiliations
1
University of New South Wales, Sydney, NSW, Australia m.valenzuela@unsw.edu.au.
2
Harvard Medical School, Boston, MA.
PMID:
37099352
DOI:
10.1056/NEJMc2301380
No abstract available
Publication types
Letter
Comment
MeSH terms
Alzheimer Disease*
Humans
Positron-Emission Tomography
Substances
lecanemab